ArticleBMC infectious diseases2024

Adverse events during intravenous fosfomycin therapy in a real-life scenario. Risk factors and the potential role of therapeutic drug monitoring.

Simona Biscarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.